Search results
MHRA approves Pierre Fabre’s vibegron to treat OAB
Pharmaceutical Technology· 5 hours agoParticipants received a daily dose of either placebo, vibegron 75mg or an active control. Vibegron significantly reduced daily urination and incontinence...
Are running shoes getting too good? Why ‘technological doping’ is a growing concern for professional...
The Telegraph· 8 hours agoEvery four years, the best athletes from around the globe converge to battle it out for top honours...
Cardurion closes $260m in Series B to develop cardiovascular pipeline
Pharmaceutical Technology· 23 hours agoBoth placebo-controlled trials are currently recruiting patients across multiple locations in the US...